Graf Akcie CTMX (CytomX Therapeutics Inc). Diskuze k akciím CTMX. Aktuální informace CTMX.

Základní informace o společnosti CytomX Therapeutics Inc (Akcie CTMX)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 323.76M
Hodnota podniku (EV) 89.58M
Tržby 66.42M
EBITDA -61.99
Zisk -64.21
Růst v tržbách Q/Q -1.93 %
Růst v tržbách Y/Y -22.03 %
P/E (Cena vůči ziskům) N/A
Forward P/E N/A
EV/Sales 1.35
EV/EBITDA N/A
EV/EBIT N/A
PEG 3.88
Price/Sales 4.87
P/FCF N/A
Price/Book 6.50
Účetní hodnota na akcii 0.79
Hotovost na akcii 5.03
FCF vůči ceně -31.68 %
Počet zaměstnanců 145
Tržba na zaměstnance 458.069k
Profit margin -32.77 %
Operating margin -97.12 %
Gross margin 100.00 %
EBIT margin -96.67 %
EBITDA margin -93.33 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -11.76 %
EPS - Očekávaný růst příští rok 3.13 %
Return on assets -16.35 %
Return on equity -68.52 %
ROIC -13.37 %
ROCE -20.78 %
Dluhy/Equity 6.20
Čistý dluh/EBITDA 19.62
Current ratio 2.90
Quick Ratio 2.90
Volatilita 3.84
Beta 0.92
RSI 51.46
Cílová cena analytiků 13
Známka akcie (dle analytiků) 1.80
Insider ownership 1.15 %
Institutional ownership 82.05 %
Počet akcií 65.157M
Procento shortovaných akcií 10.33 %
Short ratio 6.01 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2015
Země United States

Finanční výsledky akcie CTMX

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$57.489$59.502$71.623$15.043$7.712$5.077$0.888
Cost Of Goods Sold-------
Gross Profit$57.489$59.502$71.623$15.043$7.712$5.077$0.888
Research And Development Expenses$131.619$103.866$92.277$54.755$28.357$28.302$10.89
SG&A Expenses$36.765$33.51$25.605$19.874$12.558$6.54$4.954
Other Operating Income Or Expenses-------
Operating Expenses$168.384$137.376$117.882$74.629$40.915$34.842$15.844
Operating Income$-110.895$-77.874$-46.259$-59.586$-33.203$-29.765$-14.956
Total Non-Operating Income/Expense$8.23$7.573$2.647$0.667$-2.161$-0.535$-0.177
Pre-Tax Income$-102.665$-70.301$-43.612$-58.919$-35.364$-30.3$-15.133
Income Taxes$-0.427$14.303$-0.513$-0.019$0.01$0.01$0.01
Income After Taxes$-102.238$-84.604$-43.099$-58.9$-35.374$-30.31$-15.143
Other Income-------
Income From Continuous Operations$-102.238$-84.604$-43.099$-58.9$-35.374$-30.31$-15.143
Income From Discontinued Operations-------
Net Income$-102.238$-84.604$-43.099$-58.9$-42.079$-34.876$-18.894
EBITDA$-110.518$-77.691$-44.226$-56.191$-30.731$-28.942$-14.289
EBIT$-110.895$-77.874$-46.259$-59.586$-33.203$-29.765$-14.956
Basic Shares Outstanding45423736911
Shares Outstanding45423736911
Basic EPS$-2.26$-2.03$-1.16$-1.63$-4.90$-35.25$-24.46
EPS - Earnings Per Share$-2.26$-2.03$-1.16$-1.63$-4.90$-35.25$-24.46
# 2020 2019 2018 2017 2016 2015
Current Ratio3.5444.54996.35525.260412.05635.9888
Long-term Debt / Capital------5.962
Debt/Equity Ratio------1.6313
Gross Margin100100100100100100
Operating Margin-192.8978-130.8763-64.5868-396.1045-430.5369-586.2714
EBIT Margin-192.8978-130.8763-64.5868-396.1045-430.5369-586.2714
EBITDA Margin-192.242-130.5687-61.7483-373.5359-398.4829-570.061
Pre-Tax Profit Margin-178.582-118.149-60.8911-391.6705-458.5581-596.8091
Net Profit Margin-177.8392-142.1868-60.1748-391.5443-545.6302-686.9411
Asset Turnover0.16850.13020.18010.07550.03910.0695
Inventory Turnover Ratio------
Receiveable Turnover4422.23613.42277.06416.503720.73122.7077
Days Sales In Receivables0.08250.59551.669756.122117.6063134.7991
ROE - Return On Equity-200.0235-64.6409-61.6616-75.0519-28.059538.5913
Return On Tangible Equity-209.2811-65.852-63.9992-77.725-28.6733669.0947
ROA - Return On Assets-29.957-18.5085-10.8386-29.579-17.9368-41.4853
ROI - Return On Investment-200.0235-64.641-61.6616-75.0519-28.059511524.71
Book Value Per Share1.12282.90321.81652.15073.4987-1.8365
Operating Cash Flow Per Share-1.286-6.39664.64013.1335-35.345342.5245
Free Cash Flow Per Share-1.2723-6.44554.65673.2604-33.849341.7908

Porovnání s konkurencí: Akcie CTMX

Společnost P/E PEG Růst v tržbách (roční) Růst v EPS Return on equity P/B Profit margin
CTMX N/A 3.88 -22.03 % 3.13 % -68.52 % 6.50 -32.77 %
Akcie OCUL 0.00 N/A 344.51 % 19.05 % -174.71 % 11.57 -894.31 %
Akcie OCUL 0.00 N/A 344.51 % 19.05 % -174.71 % 11.57 -894.31 %
Akcie OCUL 0.00 N/A 344.51 % 19.05 % -174.71 % 11.57 -894.31 %
Akcie OCUL 0.00 N/A 344.51 % 19.05 % -174.71 % 11.57 -894.31 %

Nedávné obchody insiderů: Akcie CTMX

Jméno Obchod Cena Objem
Debanjan Ray
Chief Financial Officer
Option
1 Aug 2018
$1.28 $3,840
Sean A. Mc Carthy
President and CEO
Option
4 Sep 2018
$1.57 $20,492
Debanjan Ray
Chief Financial Officer
Option
4 Sep 2018
$1.45 $4,350
Debanjan Ray
Chief Financial Officer
Option
1 Oct 2018
$1.45 $4,350
Sean A. Mc Carthy
President and CEO
Option
1 Nov 2018
$1.57 $10,246
Debanjan Ray
Chief Financial Officer
Option
1 Nov 2018
$1.45 $4,350
Debanjan Ray
Chief Financial Officer
Option
12 Dec 2018
$1.45 $4,350
Lloyd A Rowland
General Counsel
Nákup
4 Mar 2019
$10.33 $92,970
Sean A. Mc Carthy
President and CEO
Option
12 May 2020
$1.13 $40,680
Sean A. Mc Carthy
President and CEO
Option
21 Sep 2020
$6.61 $135,505
Sean A. Mc Carthy
President and CEO
Option
23 Dec 2020
$1.13 $113,000

Diskuze k akciím CTMX